Catholic University Industry Academic Cooperation Foundation;Hanlim Pharmaceutical Co., Ltd.
发明人:
申请号：
EP09848789.5
公开号：
EP2471535B1
申请日:
2009.10.08
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention provides a pharmaceutical composition for preventing or treating rheumatoid arthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
